Patent · US Active

Gene expression markers for colorectal cancer prognosis

US8367345B2 · kind B2 · utility

8Cited by
7References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 6, 2012
Grant dateFeb 5, 2013
Priority date
Expiry dateMar 6, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/118
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.